About Neuralink’s first CONVOY study participant. Alex became paralyzed from the neck down after a car accident. He lost the ability to create designs after the accident.

6 days ago · Over the past year, three people with paralysis have received Neuralink implants. This blog post explores how each person is using Telepathy in everyday life. ... ** The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study using our implant to control various assistive devices. The main goal ...

6 days ago · Neuralink's latest breakthrough demonstrates its brain implant's potential to control a robotic arm, as seen in a new video showing the word "Convoy" being written with just the mind. This milestone, part of Neuralink's PRIME study, aims …

6 days ago · Neuralink welcomed its first patient to its CONVOY study, which will test the feasibility of using brain-controlled assistive robotic devices. The tech company recently provided an update on all three of the participants in its PRIMARY Study: Conrad, Alex, and Brad.

Jan 31, 2025 · Elon Musk’s Neuralink suggests that a human patient might have successfully used the company’s brain chip to remotely control a robot. A short video clip posted Thursday shows a robot arm holding...

Jan 31, 2025 · Elon Musk’s Neuralink suggests that a human patient might have successfully used the company’s brain chip to remotely control a robot. A short video clip posted Thursday shows a robot arm holding...

Elon Musk’s Neuralink suggests a human patient may have successfully used its brain chip to control a robotic arm. A video posted by the neurotechnology firm shows a robotic arm writing...

Feb 3, 2025 · Neuralink has recently showcased a legitimate significant advancement in the brain computer interface technology with its ‘Convoy’ study which actually aims to enable the individuals with disabilities to control robotic arms using thought alone, reported The US Sun.

Nov 26, 2024 · Neuralink is launching a new trial named the CONVOY study, designed to extend control of external devices using its N1 brain-computer interface. This trial specifically targets people with disabilities, primarily those who are quadriplegic and unable to use their limbs.

Nov 26, 2024 · US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic arm. Founded by Elon Musk, the company said that the trial, named CONVOY, will operate with cross-enrolling from the company’s ongoing PRIME study (NCT06429735), which is being completed in the US.